Last year, MSD and Moderna started the INTerpath-002 study of the combination as adjuvant therapy for patients with stage 2 to 3b NSCLC that has been removed with surgery, without neoadjuvant ...
State Key Laboratory of Applied Organic Chemistry, Department of Chemistry, Lanzhou University, Lanzhou 730000, PR China State Key Laboratory for Animal Disease Control and Prevention, College of ...